4//SEC Filing
Jones Aranthan II 4
Accession 0001209191-20-014126
CIK 0001347178other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:02 PM ET
Size
7.7 KB
Accession
0001209191-20-014126
Insider Transaction Report
Form 4
Jones Aranthan II
Chief Corp. Affairs Officer
Transactions
- Award
Common Stock
2020-02-26+30,000→ 90,000 total - Award
Employee Stock Option (Right to Buy)
2020-02-26+70,000→ 70,000 totalExercise: $11.32Exp: 2030-02-25→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]The option vests with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001785894
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:02 PM ET
- Size
- 7.7 KB